0001225208-13-019840.txt : 20130911 0001225208-13-019840.hdr.sgml : 20130911 20130911155532 ACCESSION NUMBER: 0001225208-13-019840 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130909 FILED AS OF DATE: 20130911 DATE AS OF CHANGE: 20130911 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 131091083 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2013-09-09 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2013-09-09 4 M 0 18000.0000 88.7550 A 53489.6436 D Common Stock 2013-09-09 4 M 0 10364.0000 86.1450 A 63853.6436 D Common Stock 2013-09-09 4 S 0 767.0000 118.0961 D 63086.6436 D Common Stock 2013-09-09 4 S 0 27597.0000 117.8884 D 35489.6436 D Common Stock 12.6460 I 401(k) Plan Option (Right to Buy) 88.7550 2013-09-09 4 M 0 18000.0000 0.0000 D 2018-07-09 Common Stock 18000.0000 0.0000 D Option (Right to Buy) 86.1450 2013-09-09 4 M 0 10364.0000 0.0000 D 2020-12-08 Common Stock 10364.0000 10364.0000 D Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Includes 10.0379 shares acquired under the Company's Dividend Reinvestment Plan from July 27, 2013 to September 9, 2013. Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from July 27, 2013 to September 9, 2013. Represents the weighted average sales price for price increments ranging from $118.07 to $118.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $117.07 to $118.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 0.538 shares acquired under the Company's 401(k) Plan from July 27, 2013 to September 9, 2013. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan. Options fully vested in accordance with schedule upon achievement of certain performance criteria. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Options vested in accordance with schedule upon achievement of certain performance criteria. Myra McGinley, Attorney-in-Fact 2013-09-11